CV Sciences

Read more
Joseph Dowling's photo - CEO of CV Sciences

CEO

Joseph Dowling

CEO Approval Rating

76/100

Founded:

2010

Status:

PublicIndependent CompanyOTCMKTSCVSI

CV SCIENCES TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

CV Sciences's company profile
Joseph Dowling's photo - CEO of CV Sciences

Joseph Dowling

CEO

76/100
78
$16.6M
$20.4M
View Profile
1
CV Sciences's Competitor - InMed logo
Eric A Adams's photo - President & CEO of InMed

Eric A Adams

President & CEO

96/100
13
$30M
$ < 1M
View Profile
2
CV Sciences's Competitor - GW Pharmaceuticals logo
Justin Gover's photo - CEO of GW Pharmaceuticals

Justin Gover

CEO

86/100
1,161
$31M
$559M
View Profile
3
CV Sciences's Competitor - Axim Biotechnologies logo
John W. Huemoeller's photo - CEO of Axim Biotechnologies

John W. Huemoeller

CEO

87/100
5
$4.6M
$3.3M
View Profile
4
CV Sciences's Competitor - Kalytera Therapeutics logo
Robert Farrell, J.D's photo - CEO of Kalytera Therapeutics

Robert Farrell, J.D

CEO

70/100
$10.7M
View Profile
5
CV Sciences's Competitor - Cannabics Pharmaceuticals logo
Eyal Barad's photo - Co-Founder & CEO of Cannabics Pharmaceuticals

Eyal Barad

Co-Founder & CEO

89/100
8
- -
$ < 1M
View Profile
6
CV Sciences's Competitor - CBDistillery logo
Chase Terwilliger's photo - CEO of CBDistillery

Chase Terwilliger

CEO

90/100
100
- -
$41M
View Profile
7
CV Sciences's Competitor - Tetra Bio-Pharma logo
Guy Chamberland's photo - CEO of Tetra Bio-Pharma

Guy Chamberland

CEO

90/100
33
$47.8M
$ < 1M
View Profile
8
CV Sciences's Competitor - Zynerba logo
Armando Anido's photo - Chairman & CEO of Zynerba

Armando Anido

Chairman & CEO

84/100
25
$55M
$ < 1M
View Profile
9
CV Sciences's Competitor - InstyMeds logo
Brad Schraut's photo - CEO of InstyMeds

Brad Schraut

CEO

85/100
40
- -
$4.5M
View Profile
10
CV Sciences's Competitor - Organigram logo
Beena Goldenberg's photo - CEO of Organigram

Beena Goldenberg

CEO

82/100
693
$503.6M
$60.2M
View Profile
11
CV Sciences's Competitor - Zogenix logo
Stephen J. Farr's photo - President & CEO of Zogenix

Stephen J. Farr

President & CEO

81/100
90
$494.3M
$43.8M
View Profile
12
CV Sciences's Competitor - Espero Pharma logo
Quang Pham's photo - Chairman & CEO of Espero Pharma

Quang Pham

Chairman & CEO

82/100
- -
$4M
View Profile

Missing a competitor? Contribute!

InMed has been one of CV Sciences's top competitors. InMed's headquarters is in Vancouver, British Columbia, and was founded in 1981. InMed is in the Health Care Services industry. InMed generates 1.68% of CV Sciences's revenue.

GW Pharmaceuticals is one of CV Sciences's top rivals. GW Pharmaceuticals is a Public company that was founded in Cambridge, England in 1998. GW Pharmaceuticals operates in the Biotechnology industry. GW Pharmaceuticals has 1,083 more employees vs. CV Sciences.

Axim Biotechnologies is perceived as one of CV Sciences's biggest rivals. Axim Biotechnologies was founded in 2018, and is headquartered in San Diego, California. Axim Biotechnologies operates in the Pharmaceuticals industry. Axim Biotechnologies generates $17.1M less revenue vs. CV Sciences.

CV Sciences Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$20.4M

CV Sciences's revenue is the ranked 6th among it's top 10 competitors. The top 10 competitors average 68.6M. Over the last three quarters, CV Sciences's revenue has decreased by 7.8%. Specifically, in Q2 2021's revenue was $5.1M; in Q1 2021, it was $4.8M; in Q3 2020, it was $5.6M.

CV Sciences Acquisitions

No recent acquisitions found related to CV Sciences

CV Sciences Funding History

Since CV Sciences was founded in 2010, it has participated in 9 rounds of funding. In total CV Sciences has raised $16.6M. CV Sciences' last funding round was on Apr 2020 for a total of $2.9M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt - PPP (CARES Act)
Apr 2020
$2.9M
Debt - PPP (CARES Act)
Apr 2020
$2M - $5M
Debt
Feb 2017
$750K
-
Debt
May 2016
$2M
-
Debt
May 2015
$510K
-

Since CV Sciences was founded in 2010, it has participated in 9 rounds of funding. In total CV Sciences has raised $16.6M. CV Sciences' last funding round was on Apr 2020 for a total of $2.9M

CV Sciences Investments

No recent investments found related to CV Sciences

CV Sciences News

July 1, 2021Drug Store News

CV Sciences debuts 2 PlusCBD gummies

PlusCBD Calm and Sleep are formulated to support healthy stress responses and sleep cycles, respectiv... See more »
June 29, 2021MarketScreener

EXECUTIVE EMPLOYMENT AGREEMENT (Form 8-K)

(marketscreener.com) EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT is entered in... See more »
June 14, 2021MarketScreener

A Delaware corporation (Form 8-K)

(marketscreener.com) a Delaware corporation In accordance with Article IX of the bylaws of CV Science... See more »
May 14, 2021FoodNavigator-USA

CV Sciences' revenue plummets, reflecting overall contraction of CBD market

CBD products manufacturer CV Sciences has recorded a sharp decline in revenue, mirroring reports of a... See more »
May 6, 2021BioSpace

CV Sciences, Inc. to Announce First Quarter 2021 Results on May 13, 2021

CV Sciences, Inc., a preeminent supplier and manufacturer of hemp cannabidiol products, announced tha... See more »

CV Sciences Press Releases

April 13, 2021centralcharts

CV Sciences and Alkemist Labs Form Partnership to Support the National Institute of Standards and Technology's Cannabis Quality Assurance Program

SAN DIEGO, April 13, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Scie... See more »
January 5, 2021GlobeNewswire

CV Sciences, Inc. Announces Launch of ProCBD Product Line

Clinical Strength ProCBD is Supported by Clinical Research and Available Exclusively Through Health P... See more »
December 8, 2020GlobeNewswire

CV Sciences, Inc. Announces Closing of Committed Equity Financing Transaction

SAN DIEGO, Dec. 08, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Scien... See more »
June 2, 2020centralcharts

CV Sciences, Inc. Announces Publication of Two Research Studies Demonstrating the Safety and Health Benefits of PlusCBD Products

SAN DIEGO, June 02, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Scien... See more »
May 20, 2020Emerging Growth

CVSI) Receives Formal Notice of Patent Issuance from USPTO

Miami, FL - May 20, 2020 (EmergingGrowth.com NewsWire) - EmergingGrowth.com, a leading independent sm... See more »
April 30, 2020GlobeNewswire

CV Sciences, Inc. to Announce First Quarter 2019 Results on May 8, 2020

SAN DIEGO, April 30, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Scie... See more »
January 23, 2020StreetInsider

CV Sciences, Inc. Launches Updated +PlusCBD Oil Website to Enhance User Experience and Drive Increased E-Commerce Sales

Refreshed Website Guides Visitors on their Hemp CBD Journey with Multimedia Educational Resources, In... See more »

CV Sciences Videos

July 22, 2021CV Sciences Youtube Channel

"PlusCBD Calm Gummies" on YOUTUBE

July 22, 2021CV Sciences Youtube Channel

"PlusCBD Sleep Gummies" on YOUTUBE

July 2, 2021CV Sciences Youtube Channel

"PlusCBD Original Formula Softgels" on YOUTUBE

July 2, 2021CV Sciences Youtube Channel

"PlusCBD Raw Formula Softgels" on YOUTUBE

June 28, 2021CV Sciences Youtube Channel

"4:41am" on YOUTUBE

Social Media

CV Sciences Headquarters

10070 Barnes Canyon Road

San Diego, Nevada92121

1-855-758-7223

Driving Directions »

Trending Companies

CV Sciences Summary

ABOUT

Overview

CV Sciences is a life science company that focuses on developing and commercializing novel cannabidiol‐based medicines. CV Sciences was founded in 2010. CV Sciences' headquarters is located in San Diego, Nevada, USA 92121. It has raised 16.6M in 9 rou...

CEO

CV Sciences's CEO, Joseph Dowling, currently has an approval rating of 76%. CV Sciences's primary competitors are InMed, GW Pharmaceuticals & Axim Biotechnologies.

Frequently Asked Questions about CV Sciences

  1. When was CV Sciences founded?

    CV Sciences was founded in 2010
  2. Who is CV Sciences's CEO?

    CV Sciences's CEO is Joseph Dowling
  3. How much revenue does CV Sciences generate?

    CV Sciences generates $20.4M in revenue
  4. How much funding does CV Sciences have?

    CV Sciences has historically raised $16.6M in funding
  1. Where is CV Sciences's headquarters?

    CV Sciences's headquarters is in San Diego Nevada, USA
  2. How many employees does CV Sciences have?

    CV Sciences has 78 employees
  3. What sector does CV Sciences operate in?

    CV Sciences is in Cannabis Products
  4. Who are CV Sciences's competitors?

    CV Sciences's top competitors are InMed, GW Pharmaceuticals, Axim Biotechnologies